182 related articles for article (PubMed ID: 4087565)
1. Effects of denopamine (TA-064), a new positive inotropic agent, on myocardial oxygen consumption and left ventricular dimension in anesthetized dogs.
Ikeo T; Nagao T
Jpn J Pharmacol; 1985 Oct; 39(2):179-89. PubMed ID: 4087565
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs.
Ikeo T; Nagao T; Suzuki T; Yabana H; Nakajima H
Jpn J Pharmacol; 1985 Oct; 39(2):191-9. PubMed ID: 4087566
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
Ikeo T; Nagao T; Murata S; Yabana H; Sato M; Nakajima H
Arzneimittelforschung; 1986 Jul; 36(7):1063-8. PubMed ID: 3768073
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of left ventricular function in aged SHR by volume loading and the positive inotropic effect of denopamine.
Ikeo T; Nagao T
Jpn J Pharmacol; 1986 May; 41(1):1-6. PubMed ID: 3735807
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic administration of denopamine (TA-064), a new positive inotropic agent, on cardiac response of rats to denopamine.
Yabana H; Naito K; Nagao T
Jpn J Pharmacol; 1986 Sep; 42(1):87-97. PubMed ID: 3795620
[TBL] [Abstract][Full Text] [Related]
6. Denopamine (beta 1-selective adrenergic receptor agonist) and isoproterenol (non-selective beta-adrenergic receptor agonist) equally increase heart rate and myocardial oxygen consumption in dog heart.
Futaki S; Goto Y; Ohgoshi Y; Yaku H; Kawaguchi O; Suga H
Jpn Circ J; 1991 Oct; 55(10):972-82. PubMed ID: 1683912
[TBL] [Abstract][Full Text] [Related]
7. Weak arrhythmogenic property of the new cardiotonic agent denopamine in dogs: comparison with catecholamines.
Narita H; Yabana H; Kikkawa K; Miyazaki K; Ikeo T; Nagao T
Jpn J Pharmacol; 1986 Jul; 41(3):335-44. PubMed ID: 3761749
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological analysis of positive chrono- and inotropic responses to denopamine (TA-064) in dog cross-circulated atrial and ventricular preparations.
Akahane K; Furukawa Y; Karasawa Y; Ren LM; Chiba S
Jpn J Pharmacol; 1990 Jan; 52(1):69-79. PubMed ID: 1968521
[TBL] [Abstract][Full Text] [Related]
9. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
Itoh S; Mori T; Fujiki H; Tominaga M
Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
[TBL] [Abstract][Full Text] [Related]
10. An explanation of bell-shaped, dose-positive inotropic effect curves for denopamine in canine right ventricular muscle.
Yokoyama H; Ishii K; Yanagisawa T; Taira N
J Cardiovasc Pharmacol; 1989 Oct; 14(4):570-6. PubMed ID: 2478770
[TBL] [Abstract][Full Text] [Related]
11. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
Harkin CP; Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
[TBL] [Abstract][Full Text] [Related]
12. Effect of isoproterenol on regional myocardial segment work, O2 consumption, and oxygen balance.
Kedem J; Sonn J; Scheinowitz M; Weiss HR
Res Exp Med (Berl); 1992; 192(5):323-34. PubMed ID: 1439197
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of a new inotropic agent, denopamine (TA-064); with reference to it's effects on cardiac hemodynamics and metabolism.
Kino M; Hirota Y; Saitoh T; Nakayama A; Hara M; Sawada K; Yamamoto S; Suwa M; Kubo S; Kawamura K
Jpn Circ J; 1986 Jul; 50(7):644-51. PubMed ID: 3773230
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
[TBL] [Abstract][Full Text] [Related]
15. Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs.
Pagel PS; Hettrick DA; Warltier DC
Anesthesiology; 1993 Oct; 79(4):753-65. PubMed ID: 8214755
[TBL] [Abstract][Full Text] [Related]
16. [The energetics and economics of the cardiac pump function].
Hoeft A; Korb H; Hellige G; Sonntag H; Kettler D
Anaesthesist; 1991 Sep; 40(9):465-78. PubMed ID: 1952041
[TBL] [Abstract][Full Text] [Related]
17. Improvement by denopamine (TA-064) of pentobarbital-induced cardiac failure in the dog heart-lung preparation.
Nunoki K; Goto T; Satoh K; Taira N
Heart Vessels; 1985 Nov; 1(4):216-9. PubMed ID: 3831029
[TBL] [Abstract][Full Text] [Related]
18. Details of mode and mechanism of action of denopamine, a new orally active cardiotonic agent with affinity for beta 1-receptors.
Yokoyama H; Yanagisawa T; Taira N
J Cardiovasc Pharmacol; 1988 Sep; 12(3):323-31. PubMed ID: 2464105
[TBL] [Abstract][Full Text] [Related]
19. Comparative positive inotropic effects of TA-064 (denopamine), a new cardiotonic agent, and isoproterenol and ouabain on guinea pig ventricular muscles.
Sato T; Imanishi S; Arita M
J Cardiovasc Pharmacol; 1989 Oct; 14(4):519-25. PubMed ID: 2478764
[TBL] [Abstract][Full Text] [Related]
20. Effect of denopamine on the phosphorylation of cardiac muscle proteins in the perfused guinea-pig heart. Comparison with isoproterenol.
Sasaki Y; Yabana H; Nagao T; Takeyama S
Biochem Pharmacol; 1988 Feb; 37(4):679-86. PubMed ID: 2829921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
